United States · 
Who invested in Exavir Therapeutics?
Exavir Therapeutics's investors include Y Combinator, AlleyCorp and National Institute of Allergy and Infectious Diseases.
United States · Funded startup
Who invested in Exavir Therapeutics
Funding summaryUpdated 26 Oct 2026
$3.0Mraised across 1 round since 2023, from 1 source
- Latest round
- Grant, $3.0MAug 2023
- Investors
- 3
The rounds
- Aug 2023
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Exavir Therapeutics
How much has Exavir Therapeutics raised?
Exavir Therapeutics has raised $3.0M across 1 round since 2023.
When did Exavir Therapeutics last raise?
Exavir Therapeutics's most recent round was a Grant of $3.0M in Aug 2023.
What was Exavir Therapeutics's biggest round?
Its most recent round, $3.0M in Aug 2023, is also its largest on record.
Who backed Exavir Therapeutics first?
Exavir Therapeutics's first round on record, in Aug 2023, was backed by Y Combinator, AlleyCorp and National Institute of Allergy and Infectious Diseases.
What stage is Exavir Therapeutics at?
Exavir Therapeutics's latest named round is a Grant, in Aug 2023.
Where is Exavir Therapeutics based?
Exavir Therapeutics is based in the United States.
Companies like Exavir Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.